Pluripotent reprogramming of fibroblasts by lentiviralmediated insertion of SOX2, C-MYC, and TCL-1A

Stem Cells and Development

Volumn 20, Issue 1, 2011, Pages 169-180

  Picanço Castro, Virgínia ^a,b   Russo Carbolante, Elisa ^b,c   Reis, Luiza Cunha Junqueira ^a,b   Fraga, Ana Maria ^b,c   De Magalhães, Danielle Aparecida Rosa ^a,b   Orellana, Maristela Delgado ^a,b   Panepucci, Rodrigo Alexandre ^a,b   Pereira, Lygia Veiga ^b,c   Covas, Dimas Tadeu ^a,b,c  

^a Center for Cell Therapy and Regional Blood Center   (Brazil)

^b National Institute of Science and Technology in Stem Cell and Cell Therapy   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; MYC PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TCL 1A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL STRUCTURE; CONTROLLED STUDY; EMBRYONIC STEM CELL; FIBROBLAST; GENE EXPRESSION; GENE INSERTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

CELL DIFFERENTIATION; DERMIS; DNA; EMBRYOID BODIES; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENE TRANSFER TECHNIQUES; GENOME, HUMAN; HUMANS; KINETICS; LENTIVIRUS; MODELS, BIOLOGICAL; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; SOXB1 TRANSCRIPTION FACTORS;

EID: 77958549136     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0424     Document Type: Article

References (62)

1. Evans MJ and MH Kaufman. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
2. Martin GR. (1981). Isolation of a pluripotent cell line fromearly mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634-7638.
3. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
4. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
5. Maherali N, R Sridharan, W Xie, J Utikal, S Eminli, K Arnold, M Stadtfeld, R Yachechko, J Tchieu, R Jaenisch, K Plath and K Hochedlinger. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1:55-70.
6. Okita K, M Nakagawa, H Hyenjong, T Ichisaka and S Yamanaka. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
7. Wernig M, A Meissner, R Foreman, T Brambrink, M Ku, K Hochedlinger, BE Bernstein and R Jaenisch. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324. (Pubitemid 47080337)
8. Zhao XY, W Li, Z Lv, L Liu, M Tong, T Hai, J Hao, CL Guo, QW Ma, L Wang, F Zeng and Q Zhou. (2009). iPS cells produce viable mice through tetraploid complementation. Nature 461:86-90.
9. Aoi T, K Yae, M Nakagawa, T Ichisaka, K Okita, K Takahashi, T Chiba and S Yamanaka. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321:699-702.
10. Lowry WE, L Richter, R Yachechko, AD Pyle, J Tchieu, R Sridharan, AT Clark and K Plath. (2008). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105:2883-2888.
11. Stadtfeld M, M Nagaya, J Utikal, G Weir and K Hochedlinger. (2008). Induced pluripotent stem cells generated without viral integration. Science 322:945-949.
12. Eminli S, J Utikal, K Arnold, R Jaenisch and K Hochedlinger. (2008). Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26:2467-2474.
13. Hanna J, S Markoulaki, P Schorderet, BW Carey, C Beard, M Wernig, MP Creyghton, EJ Steine, JP Cassady, R Foreman, CJ Lengner, JA Dausman and R Jaenisch. (2008). Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133:250-264.
14. Kim JB, H Zaehres, G Wu, L Gentile, K Ko, V Sebastiano, MJ Arauzo-Bravo, D Ruau, DW Han, M Zenke and HR Scholer. (2008). Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454: 646-650.
15. Maehr R, S Chen, M Snitow, T Ludwig, L Yagasaki, R Goland, RL Leibel and DA Melton. (2009). Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci USA 106:15523-15524.
16. Stadtfeld M, K Brennand and K Hochedlinger. (2008). Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol 18:890-894.
17. Huangfu D, K Osafune, R Maehr, W Guo, A Eijkelenboom, S Chen, W Muhlestein and DA Melton. (2008). Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269-1275.
18. Nakagawa M, M Koyanagi, K Tanabe, K Takahashi, T Ichisaka, T Aoi, K Okita, Y Mochiduki, N Takizawa and S Yamanaka. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101-106.
19. Shi Y, C Desponts, JT Do, HS Hahm, HR Scholer and S Ding. (2008). Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3:568-574.
20. Wernig M, A Meissner, JP Cassady and R Jaenisch. (2008). c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2:10-12.
21. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, Slukvin, II and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
22. Choi KD, J Yu, K Smuga-Otto, G Salvagiotto,WRehrauer, M Vodyanik, J Thomson and I Slukvin. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559-567.
23. Hanna J, M Wernig, S Markoulaki, CW Sun, A Meissner, JP Cassady, C Beard, T Brambrink, LC Wu, TM Townes and R Jaenisch. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318:1920-1923.
24. Raya A, I Rodriguez-Piza, G Guenechea, R Vassena, S Navarro, MJ Barrero, A Consiglio, M Castella, P Rio, E Sleep, F Gonzalez, G Tiscornia, E Garreta, T Aasen, A Veiga, IM Verma, J Surralles, J Bueren and JC Izpisua Belmonte. (2009). Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460:53-59.
25. Tanaka T, S Tohyama, M Murata, F Nomura, T Kaneko, H Chen, F Hattori, T Egashira, T Seki, Y Ohno, U Koshimizu, S Yuasa, S Ogawa, S Yamanaka, K Yasuda and K Fukuda. (2009). In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun 385:497-502.
26. Narazaki G, H Uosaki, M Teranishi, K Okita, B Kim, S Matsuoka, S Yamanaka and JK Yamashita. (2008). Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118:498-506.
27. Picanco V, S Heinz, D Bott, M Behrmann, DT Covas, E Seifried and T Tonn. (2007). Recombinant expression of coagulation factor VIII in hepatic and non-hepatic cell lines stably transduced with third generation lentiviral vectors comprising the minimal factor VIII promoter. Cytotherapy 9:785-794.
28. Zufferey R, D Nagy, RJ Mandel, L Naldini and D Trono. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871-875.
29. Mastromarino P, C Conti, P Goldoni, B Hauttecoeur and N Orsi. (1987). Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. J Gen Virol 68:2359-2369.
30. Follenzi A and L Naldini. (2002). Generation of HIV-1 derived lentiviral vectors. Methods Enzymol 346:454-465.
31. McGlynn LK, CR Mueller, M Begbie, CR Notley and D Lillicrap. (1996). Role of the liver-enriched transcription factor hepatocyte nuclear factor 1 in transcriptional regulation of the factor V111 gene. Mol Cell Biol 16:1936-1945.
32. Tesar PJ, JG Chenoweth, FA Brook, TJ Davies, EP Evans, DL Mack, RL Gardner and RD McKay. (2007). New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448:196-199.
33. Takahashi K, K Okita, M Nakagawa and S Yamanaka. (2007). Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2:3081-3089.
34. de Hoon MJ, S Imoto, J Nolan and S Miyano. (2004). Open source clustering software. Bioinformatics 20:1453-1454.
35. Saldanha AJ. (2004). Java Treeview-extensible visualization of microarray data. Bioinformatics 20:3246-3248.
36. Tonn T, C Herder, S Becker, E Seifried and M Grez. (2002). Generation and characterization of human hematopoietic cell lines expressing factor VIII. J Hematother Stem Cell Res 11:695-704.
37. Herder C, T Tonn, R Oostendorp, S Becker, U Keller, C Peschel, M Grez and E Seifried. (2003). Sustained expansion and transgene expression of coagulation factor VIIItransduced cord blood-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 23:2266-2272.
38. Follenzi A and L Naldini. (2002). HIV-based vectors. Preparation and use. Methods Mol Med 69:259-274.
39. Loh YH, S Agarwal, IH Park, A Urbach, H Huo, GC Heffner, K Kim, JD Miller, K Ng and GQ Daley. (2009). Generation of induced pluripotent stem cells from human blood. Blood 113:5476-5479.
40. Park IH, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, MW Lensch and GQ Daley. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.
41. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
42. Huang J, T Chen, X Liu, J Jiang, J Li, D Li, XS Liu, W Li, J Kang and G Pei. (2009). More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Cell Res 19:1127-1138.
43. Kim JB, B Greber, MJ Arauzo-Bravo, J Meyer, KI Park, H Zaehres and HR Scholer. (2009). Direct reprogramming of human neural stem cells by OCT4. Nature 461:649-653.
44. Utikal J, N Maherali,WKulalert and K Hochedlinger. (2009). Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci 122:3502-3510.
45. Zhou W and CR Freed. (2009). Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27:2667-2674.
46. Feng B, J Jiang, P Kraus, JH Ng, JC Heng, YS Chan, LP Yaw, W Zhang, YH Loh, J Han, VB Vega, V Cacheux-Rataboul, B Lim, T Lufkin and HH Ng. (2009). Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol 11:197-203.
47. Draper JS, HD Moore, LN Ruban, PJ Gokhale and PW Andrews. (2004). Culture and characterization of human embryonic stem cells. Stem Cells Dev 13:325-336.
48. Mitalipova MM, RR Rao, DM Hoyer, JA Johnson, LF Meisner, KL Jones, S Dalton and SL Stice. (2005). Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol 23:19-20. (Pubitemid 41724618)
49. Chin MH, MJ Mason, W Xie, S Volinia, M Singer, C Peterson, G Ambartsumyan, O Aimiuwu, L Richter, J Zhang, I Khvorostov, V Ott, M Grunstein, N Lavon, N Benvenisty, CM Croce, AT Clark, T Baxter, AD Pyle, MA Teitell, M Pelegrini, K Plath and WE Lowry. (2009). Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5:111-123.
50. Niwa H. (2007). How is pluripotency determined and maintained? Development 134:635-646.
51. Storm MP, HK Bone, CG Beck, PY Bourillot, V Schreiber, T Damiano, A Nelson, P Savatier and MJ Welham. (2007). Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J Biol Chem 282:6265-6273.
52. Suzuki A, A Raya, Y Kawakami, M Morita, T Matsui, K Nakashima, FH Gage, C Rodriguez-Esteban and JC Izpisua Belmonte. (2006). Maintenance of embryonic stem cell pluripotency by Nanog-mediated reversal of mesoderm specification. Nat Clin Pract Cardiovasc Med 3 Suppl 1:S114-S122.
53. Wu H, KJ Kim, K Mehta, S Paxia, A Sundstrom, T Anantharaman, AI Kuraishy, T Doan, J Ghosh, AD Pyle, A Clark, W Lowry, G Fan, T Baxter, B Mishra, Y Sun and MA Teitell. (2008). Copy number variant analysis of human embryonic stem cells. Stem Cells 26:1484-1489.
54. Mitsui K, Y Tokuzawa, H Itoh, K Segawa, M Murakami, K Takahashi, M Maruyama, M Maeda and S Yamanaka. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631-642.
55. Hatano SY, M Tada, H Kimura, S Yamaguchi, T Kono, T Nakano, H Suemori, N Nakatsuji and T Tada. (2005). Pluripotential competence of cells associated with Nanog activity. Mech Dev 122:67-79.
56. Boyer LA, TI Lee, MF Cole, SE Johnstone, SS Levine, JP Zucker, MG Guenther, RM Kumar, HL Murray, RG Jenner, DK Gifford, DA Melton, R Jaenisch and RA Young. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122:947-956.
57. Takahashi K, M Murakami and S Yamanaka. (2005). Role of the phosphoinositide 3-kinase pathway in mouse embryonic stem (ES) cells. Biochem Soc Trans 33:1522-1525. (Pubitemid 41779729)
58. Sun H, R Lesche, DM Li, J Liliental, H Zhang, J Gao, N Gavrilova, B Mueller, X Liu and H Wu. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt=protein kinase B signaling pathway. Proc Natl Acad Sci USA 96:6199-6204.
59. Hong H, K Takahashi, T Ichisaka, T Aoi, O Kanagawa, M Nakagawa, K Okita and S Yamanaka. (2009). Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 460:1132-1135.
60. Kawamura T, J Suzuki, YV Wang, S Menendez, LB Morera, A Raya, GM Wahl and JC Belmonte. (2009). Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460:1140-1144.
61. Lin T, C Chao, S Saito, SJ Mazur, ME Murphy, E Appella and Y Xu. (2005). p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7:165-171.
62. Mikkelsen TS, J Hanna, X Zhang, M Ku, M Wernig, P Schorderet, BE Bernstein, R Jaenisch, ES Lander and A Meissner. (2008). Dissecting direct reprogramming through integrative genomic analysis. Nature 454:49-55.